![Jonathan Poole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Poole
Director/Board Member at
ACADIA PHARMACEUTICALS INC.
Net worth: 43 537 $ as of 2026-05-30
Profile
Jonathan Michael Poole is Director at ACADIA Pharmaceuticals, Inc. since 2026.
Mr. Poole is Senior Vice President-Finance at Vertex Pharmaceuticals, Inc. since 2020.
Former roles include Independent Director at Codiak BioSciences, Inc., Senior Vice President at Shire Plc from 2006 to 2014, Chief Financial & Accounting Officer at Genocea Biosciences, Inc. from 2014 to 2018, Investment Manager at Avanti Capital PLC, Investment Manager at Odyssey Partners Ltd. from 2004 to 2007, Head-Strategic Planning & Portfolio Management at Shire Human Genetic Therapies, Inc., and Chief Financial Officer & Treasurer at Evelo Biosciences, Inc. from 2018 to 2020.
Education includes an undergraduate degree from the University of Durham and an MBA from London Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-28 | 2,010 ( 0% ) | 43 537 $ | 2026-05-30 |
Jonathan Poole active positions
| Companies | Position | Start |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Director/Board Member | 2026-03-02 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2020-02-29 |
Former positions of Jonathan Poole
| Companies | Position | End |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Director of Finance/CFO | 2020-03-26 |
| GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 2018-03-22 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | 2014-02-28 |
Odyssey Partners Ltd.
 Odyssey Partners Ltd. Investment ManagersFinance Provides Investment advisers | Corporate Officer/Principal | 2007-01-30 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Corporate Officer/Principal | - |
Training of Jonathan Poole
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Avanti Capital PLC
 Avanti Capital PLC Financial ConglomeratesFinance Provides investment management and ancillary services | Finance |
University of Durham
 University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Odyssey Partners Ltd.
Odyssey Partners Ltd. Investment ManagersFinance Provides Investment advisers | Finance |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
- Stock Market
- Insiders
- Jonathan Poole
Choose MarketScreener 
